Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis Academic Article uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Molecular Targeted Therapy

abstract

  • The use of targeted agents in the multimodal treatment of patients with RCC and brain metastasis was not associated with excessive neurologic adverse events. Clear cell histology, favorable MSKCC risk status, and solitary brain metastasis are associated with more favorable OS.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.clgc.2014.06.002

PubMed ID

  • 25023939

Additional Document Info

start page

  • 59

end page

  • 66

volume

  • 13

number

  • 1